Literature DB >> 26990889

The significance of Delphian lymph node in papillary thyroid cancer.

Zhuo Tan1, Ming-Hua Ge1, Chuan-Ming Zheng1, Qing-Liang Wang1, Xi-Lin Nie1, Lie-Hao Jiang1.   

Abstract

AIM: To investigate the clinical significance of the DLN metastasis in papillary thyroid cancer (PTC).
METHODS: A total of 231 PTC patients who underwent first surgical treatment in the Department of Hand and Neck Surgery of Zhejiang Cancer Hospital from January 2013 to June 2014 were enrolled. The relationship between Delphian lymph node (DLN) metastasis and patient age, gender, tumor size, tumor number, unilateral or bilateral, capsular invasion, pretracheal and paratracheal node metastasis, and lateral node metastasis was analyzed.
RESULTS: Within 231 cases, 69 showed DLN, but only 19 (8.23%) were found with metastasis. In the univariate analysis, DLN metastasis was significantly associated with tumor size (P = 0.023), capsular invasion (P = 0.001), pretracheal or paratracheal node metastasis (P = 0.003) and lateral node metastasis (P = 0.001), while there were no significant correlation between DLN metastasis and gender (P = 0.976), age (P = 0.976), tumor number (P = 0.234) and unilateral or bilateral (P = 0.724). In the multivariate analysis, capsular invasion was an independent risk factor of DLN metastasis (P < 0.05, odds ratio = 10.15).
CONCLUSION: Capsular invasion is an independent risk factor of DLN metastasis and DLN metastasis could be used as a predictor of lateral node metastasis. The dissection of DLN in PTC patients is recommended and lateral lymph node should be evaluated for patients with DLN positive.

Entities:  

Keywords:  Delphian lymph node; lateral lymph node; papillary thyroid cancer

Mesh:

Year:  2016        PMID: 26990889     DOI: 10.1111/ajco.12480

Source DB:  PubMed          Journal:  Asia Pac J Clin Oncol        ISSN: 1743-7555            Impact factor:   2.601


  10 in total

1.  Skeleton labeled 13C-carbon nanoparticles for the imaging and quantification in tumor drainage lymph nodes.

Authors:  Ping Xie; Qian Xin; Sheng-Tao Yang; Tiantian He; Yuanfang Huang; Guangfu Zeng; Maosheng Ran; Xiaohai Tang
Journal:  Int J Nanomedicine       Date:  2017-07-11

2.  Patterns and clinical significance of cervical lymph node metastasis in papillary thyroid cancer patients with Delphian lymph node metastasis.

Authors:  Guibin Zheng; Hua Zhang; Shaolong Hao; Chengxin Liu; Jie Xu; Jinyao Ning; Guochang Wu; Lixin Jiang; Guojun Li; Haitao Zheng; Xicheng Song
Journal:  Oncotarget       Date:  2017-07-06

3.  Clinical implications of Delphian lymph node metastasis in papillary thyroid carcinoma: a single-institution study, systemic review and meta-analysis.

Authors:  Bin Wang; Xing-Zhu Wen; Wei Zhang; Ming Qiu
Journal:  J Otolaryngol Head Neck Surg       Date:  2019-08-30

4.  Diagnostic Model Incorporating Clinicopathological Characteristics of Delphian Lymph Node Metastasis Risk Profiles in Papillary Thyroid Cancer.

Authors:  Xingchen Li; Yuansheng Duan; Dandan Liu; Hongwei Liu; Mengqian Zhou; Kai Yue; Yanjie Shuai; Yu Wang; Chenyan Ji; Chao Jing; Yansheng Wu; Xudong Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-25       Impact factor: 5.555

5.  Nomograms Combining Ultrasonic Features With Clinical and Pathological Features for Estimation of Delphian Lymph Node Metastasis Risk in Papillary Thyroid Carcinoma.

Authors:  Qi Qi; Pan Xu; Cheng Zhang; Suping Guo; Xingzhi Huang; Songli Chen; Yaohui Li; Aiyun Zhou
Journal:  Front Oncol       Date:  2021-12-23       Impact factor: 6.244

6.  The Combined Utility of HBME-1 and Galectin-3 Immunohistochemistry and BRAF V600E Mutations in the Diagnosis of Papillary Thyroid Carcinoma.

Authors:  Subramaniam Ramkumar; Shanthakumari Sivanandham
Journal:  Cureus       Date:  2021-12-10

7.  Analysis of the Clinical Value of Delphian Lymph Node Metastasis in Papillary Thyroid Carcinoma.

Authors:  Qiumei Zuo; Xin Chen; Jingyu Yang; Shuang Qiu; Yuan Zhao; Jianwei Sun
Journal:  J Oncol       Date:  2022-06-10       Impact factor: 4.501

8.  Relationship between pretracheal and/or prelaryngeal lymph node metastasis and paratracheal and lateral lymph node metastasis of papillary thyroid carcinoma: A meta-analysis.

Authors:  Bin Wang; Chun-Rong Zhu; Hong Liu; Xin-Min Yao; Jian Wu
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

9.  Diagnostic significance of CK19, galectin-3, CD56, TPO and Ki67 expression and BRAF mutation in papillary thyroid carcinoma.

Authors:  Lihua Huang; Xuming Wang; Xuan Huang; Huawei Gui; Yan Li; Qiongxia Chen; Dongling Liu; Lijiang Liu
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

10.  CDK9 is up-regulated and associated with prognosis in patients with papillary thyroid carcinoma.

Authors:  Tao Guo; De-Feng Liu; Shi-Hao Peng
Journal:  Medicine (Baltimore)       Date:  2022-02-04       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.